PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

NCT04942301 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic NSCLC

Interventions

DRUG: Endostar
DEVICE: use the vein pump to pump drugs
COMBINATION_PRODUCT: combination therapy

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.